Pages that link to "Q40351401"
Jump to navigation
Jump to search
The following pages link to Complement-mediated mechanisms in anti-GD2 monoclonal antibody therapy of murine metastatic cancer (Q40351401):
Displaying 50 items.
- Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies (Q21131216) (← links)
- MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer (Q21195215) (← links)
- NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy (Q26797345) (← links)
- Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles (Q27301841) (← links)
- Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer (Q28291499) (← links)
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions (Q33733443) (← links)
- Herceptin Conjugates Linked by EDC Boost Direct Tumor Cell Death via Programmed Tumor Cell Necrosis (Q33997021) (← links)
- A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity (Q34038079) (← links)
- Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study (Q34488726) (← links)
- 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity (Q34502756) (← links)
- Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia (Q35092616) (← links)
- Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma. (Q35587509) (← links)
- Generation of 1E8 Single Chain Fv-Fc Construct Against Human CD59. (Q35897605) (← links)
- A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer (Q36057882) (← links)
- Localization of breast cancer resistance protein (Bcrp) in endocrine organs and inhibition of its transport activity by steroid hormones. (Q36150190) (← links)
- Breast cancer resistance protein in pharmacokinetics and drug-drug interactions (Q36544862) (← links)
- Role of monoclonal antibodies in tumor-specific immunity (Q36739762) (← links)
- Disialoganglioside directed immunotherapy of neuroblastoma (Q36761416) (← links)
- The fate and effects of xenobiotics in human placenta (Q36835803) (← links)
- Immunization with N-propionyl polysialic acid–KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci (Q37066964) (← links)
- Impact of minimal tumor burden on antibody response to vaccination (Q37073447) (← links)
- BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure. (Q37135243) (← links)
- Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection (Q37189823) (← links)
- Immune therapies for neuroblastoma (Q37431356) (← links)
- Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside (Q37520179) (← links)
- Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy. (Q37592957) (← links)
- Anti-GD2 antibody therapy for GD2-expressing tumors (Q37702283) (← links)
- Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy (Q37790379) (← links)
- Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application. (Q37964490) (← links)
- Glycans as targets for therapeutic antitumor antibodies (Q38034815) (← links)
- Effect of the ATP-binding cassette transporter ABCG2 on pharmacokinetics: experimental findings and clinical implications (Q38071700) (← links)
- Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer (Q38291696) (← links)
- Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues (Q38994657) (← links)
- Accelerated tumor growth mediated by sublytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway (Q39129112) (← links)
- Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency (Q39203683) (← links)
- Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway (Q39392579) (← links)
- The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden. (Q39646209) (← links)
- Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells (Q39766135) (← links)
- Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment (Q39920192) (← links)
- Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine. (Q39926196) (← links)
- Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma (Q39960663) (← links)
- Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells (Q40078881) (← links)
- Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells. (Q40240897) (← links)
- Long-lasting protective antiviral immunity induced by passive immunotherapies requires both neutralizing and effector functions of the administered monoclonal antibody (Q41857868) (← links)
- Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model (Q42053371) (← links)
- The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats (Q42705146) (← links)
- The Effect of Female Hormones Upon Urate Transport Systems in the Mouse Kidney (Q42748119) (← links)
- Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2. (Q46860960) (← links)
- Anti-GD2 immunotherapy for neuroblastoma. (Q47554435) (← links)
- Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats (Q51136053) (← links)